← Open Payments lookup

RACHEL WALSH: Open Payments

NPI 1891746582 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,123 in 93 payments from 18 companies in 2025. Trend: 2023 $1,900 · 2024 $1,912 · 2025 $2,123

Food & beverage: $2,123
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$311
JAZZ PHARMACEUTICALS INC.7$257
GlaxoSmithKline, LLC.16$252
Regeneron Healthcare Solutions, Inc.7$197
Actelion Pharmaceuticals US, Inc.11$188
Verona Pharma, Inc.6$170
Grifols USA, LLC4$126
Boehringer Ingelheim Pharmaceuticals, Inc.5$102
ANI Pharmaceuticals, Inc.3$80
Philips North America LLC4$73

Products named: XYWAV, DUPIXENT, TRELEGY ELLIPTA, Ohtuvayre, Prolastin-C Liquid, TEZSPIRE, AIRSUPRA, OPSUMIT.

Industry payments across PA — which companies pay providers there.